Prognostic Value of ALP and LDH in Periampullary Carcinoma Patients Undergoing Surgery

Abstract

Objective

Conversion of normal cells to cancer cells is often accompanied by abnormal synthesis of serum enzymes. Both alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) have been reported to have prognostic value in a variety of malignancies. The aim of this study was to investigate the effect of preoperative serum ALP and LDH levels on the prognosis of patients with periampullary carcinoma who underwent pancreatoduodenectomy (PD).

Methods

According to the preoperative ALP or LDH values, 856 cancer patients receiving PD treatment from January 2001 to January 2019 were divided into high-ALP group and low-ALP group or high-LDH group and low-LDH group. Statistical analysis was carried out to study the differences between the high-ALP and low-ALP groups or the high-LDH and low-LDH groups. Furthermore, the possibility of preoperative ALP or LDH as prognostic factor of periampullary carcinoma was investigated.

Results

In both the high-ALP and the high-LDH groups, the prognosis of patients with periampullary carcinoma who underwent PD was worse than that of the low-ALP and low- LDH group. Even through risk factor analysis, it was found that preoperative ALP and LDH could be independent prognostic factor for patients with periampullary carcinoma who underwent PD.

Conclusion

Preoperative ALP or LDH is an independent risk factor for periampullary carcinoma.

Keywords

periampullary malignancy / pancreatoduodenectomy / alkaline phosphatase / lactate dehydrogenase / prognostic value

References

[1] YuMC, ChanKM, LeeCF, et al.. Alkaline phosphatase: does it have a role in predicting hepatocellular carcinoma recurrence?. J Gastrointest Surg, 2011, 15(8): 1440-1449

[2] ZhangJP, WangHB, LinYH, et al.. Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy. Transl Oncol, 2015, 8(6): 497-503

[3] MaisanoR, AzzarelloD, Del MedicoP, et al.. Alkaline phosphatase levels as a prognostic factor in metastatic colorectal cancer treated with the FOLFOX 4 regimen: a monoinstitutional retrospective study. Tumori, 2011, 97(1): 39-42

[4] XieY, WeiZB, DuanXW. Prognostic value of pretreatment serum alkaline phosphatase in nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 2014, 15(8): 3547-3553

[5] SonpavdeG, PondGR, BerryWR, et al.. Serum alkaline phosphatase changes predct survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy. Urol Oncol, 2012, 30(5): 607-613

[6] WeiXL, ZhangDS, HeMM, et al.. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma. Tumour Biol, 2016, 37(2): 1879-1887

[7] ChenJ, SunMX, HuaYQ, et al.. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol, 2014, 140(7): 1205-1210

[8] WangM, ZhuF, QinR, et al.. Which Is the Best Surgical Approach for the Pancreatic Cancer? A Classification of Pancreatic Cancer to Guide Operative Decisions Is Needed. Ann Surg, 2017, 265(6): E81-E82

[9] WangM, ZhangH, ZhuF, et al.. Pancreaticoduodenectomy for borderline resectable pancreatic head cancer with a modified artery-first approach technique. Hepatobiliary Pancreat Dis Int, 2017, 16(2): 215-221

[10] WangM, XuS, ZhangH, et al.. Imbedding pancreaticojejunostomy used in pure laparoscopic pancreaticoduodenectomy for nondilated pancreatic duct. Surg Endosc, 2017, 31(4): 1986-1992

[11] BakerMS, ShermanKL, StockerSJ, et al.. Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy. J Surg Oncol, 2014, 110(4): 400-406

[12] BassiC, MarchegianiG, DervenisC, et al.. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery, 2017, 161(3): 584-591

[13] Wente MN, Bassi C, DervenisC, ,eta, et al.. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 2007, 142(5): 761-768

[14] KochM, GardenOJ, PadburyR, et al.. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery, 2011, 149(5): 680-688

[15] WenteMN, VeitJA, BassiC, et al.. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery, 2007, 142(1): 20-25

[16] JiaW, WuJ, JiaH, et al.. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS One, 2015, 10(11): e0143061

[17] AzabB, BhattVR, PhookanJ, et al.. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol, 2012, 19(1): 217-224

[18] WenJ, YeF, HuangX, et al.. Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study. Medicine (Baltimore), 2015, 94(49): e2266

[19] Krenn-PilkoS, LangsenlehnerU, ThurnerEM, et al.. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer, 2014, 110(10): 2524-2530

[20] Krenn-PilkoS, LangsenlehnerU, StojakovicT, et al.. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients. Breast, 2015, 24(5): 667-672

[21] TabassumU, ReddyO, MukherjeeG. Elevated serum haptoglobin is associated with clinical outcome in triplenegative breast cancer patients. Asian Pac J Cancer Prev, 2012, 13(9): 4541-4544

[22] SickingI, EdlundK, WesbuerE, et al.. Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One, 2014, 9(10): e111306

[23] HarrisH. The human alkaline phosphatases: what we know and what we don't know. Clin Chim Acta, 1990, 186(2): 133-150

[24] YamamotoK, AwogiT, OkuyamaK, et al.. Nuclear localization of alkaline phosphatase in cultured human cancer cells. Med Electron Microsc, 2003, 36(1): 47-51

[25] WarburgO. On the origin of cancer cells. Science, 1956, 123(3191): 309-314

[26] HanX, ShengX, JonesHM, et al.. Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells. J Hematol Oncol, 2015, 8: 2

[27] KojimaY, SakuradaT. Increase in alkaline phosphatase activity in the liver of mice bearing Ehrlich ascites tumor. Cancer Res, 1976, 361: 23-27

[28] LiG, GaoJ, TaoYL, et al.. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma. Chin J Cancer, 2012, 31(4): 197-206

[29] NilssonEE, WestfallSD, McDonaldC, et al.. An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics. Cancer Chemother Pharmacol, 2002, 49(2): 93-100

[30] FaloppiL, ScartozziM, BianconiM, et al.. The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management. BMC Cancer, 2014, 14: 110

[31] ScartozziM, FaloppiL, BianconiM, et al.. The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. PLoS One, 2012, 7(3): e32653

[32] SemenzaGL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985), 2000, 884: 1474-1480

[33] ZhaX, WangF, WangY, et al.. Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis. Cancer Res, 2011, 71(1): 13-18